22nd Century Group Plans to Publicly Issue Stock and Warrants
According to a report on October 16th by Menafn, biotechnology company 22nd Century Group has announced plans for a public offering of its common stock (or alternative equivalents) and warrants to purchase common stock. All of the common stock (or equivalent) and warrants being sold in the offering will be issued by 22nd Century Group.
Dawson James Securities has been selected as the sole agent for the upcoming public offering. The company intends to use the net proceeds from this issuance for general corporate purposes.
According to reports, 22nd Century Group, Inc. is a leading biotechnology company dedicated to improving health through advanced plant technologies using reduced-nicotine tobacco, cannabis/hemp, and hop plants. The company obtained the first and only Modified Risk Tobacco Product (MRTP) authorization from the US Food and Drug Administration in December 2021.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
